DONGGUAN, Chine, 2er mars 2025 /PRNewswire/ — Fapon Biopharma, une société innovatrice en biotechnologie développant des anticorps thérapeutiques et des protéines de fusion, a le plaisir d’annoncer que la Food and Drug Administration (FDA) américaine a approuvé la demande de nouveau…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.